CD274 and breast cancer: For example, as there is a large difference in the proportion of PD-L1-positive cells between primary BC tissue and metastatic BC tissue, the assessment of PD-L1 expression can help judge treatment efficacy and prognosis when selecting patients for immunotherapy8.